Accelerate Diagnostics Inc - Company Profile
Powered by
All the data and insights you need on Accelerate Diagnostics Inc in one report.
- Save hours of research time and resources with
our up-to-date Accelerate Diagnostics Inc Strategy Report
- Understand Accelerate Diagnostics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Accelerate Diagnostics Inc (Accelerate) carries out the development and commercialization of integrated systems to identify bacteria and their mechanisms of antibiotic resistance in seriously ill patients. The company harnesses on proprietary technologies, R&D activities, and lead product, the Accelerate Pheno System. Although a history of operating losses could be a cause of concern for the company. It could find opportunities from the growing hospital acquired infections, strategic collaboration with BD, and in vitro diagnostics market in the US. However, the company’s operations could be affected due to changes in healthcare reforms, rapid technological changes, and government regulations in the medical devices sector.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer